vs

Side-by-side financial comparison of ARGENX SE (ARGX) and Interpublic Group of Companies (The) (IPG). Click either name above to swap in a different company.

ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $2.1B, roughly 1.2× Interpublic Group of Companies (The)). ARGENX SE runs the higher net margin — 35.5% vs 5.8%, a 29.6% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -4.8%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $153.6M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

The Interpublic Group of Companies, Inc. (IPG) was an American advertising company based in New York City. It consisted of the five major networks FCB, IPG Mediabrands, McCann Worldgroup, MullenLowe Group and Marketing Specialists, as well as several independent specialty agencies in the areas of public relations, sports marketing, talent representation and healthcare. Prior to the Omnicom acquisition, it was one of the "Big Four" agency companies, alongside WPP, Publicis, and Omnicom. The co...

ARGX vs IPG — Head-to-Head

Bigger by revenue
ARGX
ARGX
1.2× larger
ARGX
$2.5B
$2.1B
IPG
Growing faster (revenue YoY)
ARGX
ARGX
+88.0% gap
ARGX
83.2%
-4.8%
IPG
Higher net margin
ARGX
ARGX
29.6% more per $
ARGX
35.5%
5.8%
IPG
More free cash flow
ARGX
ARGX
$168.8M more FCF
ARGX
$322.4M
$153.6M
IPG

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ARGX
ARGX
IPG
IPG
Revenue
$2.5B
$2.1B
Net Profit
$877.2M
$124.2M
Gross Margin
89.5%
Operating Margin
28.9%
10.3%
Net Margin
35.5%
5.8%
Revenue YoY
83.2%
-4.8%
Net Profit YoY
1.3%
517.9%
EPS (diluted)
$13.25
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
IPG
IPG
Q4 25
$2.5B
Q3 25
$2.1B
Q2 25
$1.8B
$2.2B
Q1 25
$2.0B
Q4 24
$1.4B
$2.4B
Q3 24
$2.2B
Q2 24
$901.9M
$2.3B
Q1 24
$2.2B
Net Profit
ARGX
ARGX
IPG
IPG
Q4 25
$877.2M
Q3 25
$124.2M
Q2 25
$414.8M
$162.5M
Q1 25
$-85.4M
Q4 24
$865.6M
$344.5M
Q3 24
$20.1M
Q2 24
$-32.5M
$214.5M
Q1 24
$110.4M
Gross Margin
ARGX
ARGX
IPG
IPG
Q4 25
89.5%
Q3 25
Q2 25
89.2%
Q1 25
-3.2%
Q4 24
90.2%
10.1%
Q3 24
2.9%
Q2 24
89.4%
1.2%
Q1 24
-1.1%
Operating Margin
ARGX
ARGX
IPG
IPG
Q4 25
28.9%
Q3 25
10.3%
Q2 25
19.2%
11.2%
Q1 25
-2.1%
Q4 24
8.7%
23.3%
Q3 24
5.9%
Q2 24
-15.4%
13.7%
Q1 24
8.4%
Net Margin
ARGX
ARGX
IPG
IPG
Q4 25
35.5%
Q3 25
5.8%
Q2 25
23.4%
7.5%
Q1 25
-4.3%
Q4 24
64.1%
14.1%
Q3 24
0.9%
Q2 24
-3.6%
9.2%
Q1 24
5.1%
EPS (diluted)
ARGX
ARGX
IPG
IPG
Q4 25
$13.25
Q3 25
$0.34
Q2 25
$6.32
$0.44
Q1 25
$-0.23
Q4 24
$13.33
$0.92
Q3 24
$0.05
Q2 24
$-0.55
$0.57
Q1 24
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
IPG
IPG
Cash + ST InvestmentsLiquidity on hand
$3.5B
$1.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3B
$3.7B
Total Assets
$8.7B
$17.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
IPG
IPG
Q4 25
$3.5B
Q3 25
$1.5B
Q2 25
$2.1B
$1.6B
Q1 25
$1.9B
Q4 24
$1.5B
$2.2B
Q3 24
$1.5B
Q2 24
$1.4B
$1.5B
Q1 24
$1.9B
Total Debt
ARGX
ARGX
IPG
IPG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$11.0M
Q1 24
Stockholders' Equity
ARGX
ARGX
IPG
IPG
Q4 25
$7.3B
Q3 25
$3.7B
Q2 25
$6.1B
$3.7B
Q1 25
$3.6B
Q4 24
$5.5B
$3.8B
Q3 24
$3.7B
Q2 24
$4.3B
$3.8B
Q1 24
$3.8B
Total Assets
ARGX
ARGX
IPG
IPG
Q4 25
$8.7B
Q3 25
$17.0B
Q2 25
$7.2B
$17.0B
Q1 25
$17.1B
Q4 24
$6.2B
$18.3B
Q3 24
$17.1B
Q2 24
$4.8B
$17.0B
Q1 24
$17.3B
Debt / Equity
ARGX
ARGX
IPG
IPG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
IPG
IPG
Operating Cash FlowLast quarter
$323.3M
$180.1M
Free Cash FlowOCF − Capex
$322.4M
$153.6M
FCF MarginFCF / Revenue
13.0%
7.2%
Capex IntensityCapex / Revenue
0.0%
1.2%
Cash ConversionOCF / Net Profit
0.37×
1.45×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$806.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
IPG
IPG
Q4 25
$323.3M
Q3 25
$180.1M
Q2 25
$361.8M
$-96.0M
Q1 25
$-37.0M
Q4 24
$41.9M
$868.1M
Q3 24
$223.8M
Q2 24
$-124.7M
$120.7M
Q1 24
$-157.4M
Free Cash Flow
ARGX
ARGX
IPG
IPG
Q4 25
$322.4M
Q3 25
$153.6M
Q2 25
$356.6M
$-121.8M
Q1 25
$-58.5M
Q4 24
$40.9M
$833.5M
Q3 24
$186.5M
Q2 24
$-125.5M
$85.9M
Q1 24
$-192.5M
FCF Margin
ARGX
ARGX
IPG
IPG
Q4 25
13.0%
Q3 25
7.2%
Q2 25
20.1%
-5.6%
Q1 25
-2.9%
Q4 24
3.0%
34.2%
Q3 24
8.3%
Q2 24
-13.9%
3.7%
Q1 24
-8.8%
Capex Intensity
ARGX
ARGX
IPG
IPG
Q4 25
0.0%
Q3 25
1.2%
Q2 25
0.3%
1.2%
Q1 25
1.1%
Q4 24
0.1%
1.4%
Q3 24
1.7%
Q2 24
0.1%
1.5%
Q1 24
1.6%
Cash Conversion
ARGX
ARGX
IPG
IPG
Q4 25
0.37×
Q3 25
1.45×
Q2 25
0.87×
-0.59×
Q1 25
Q4 24
0.05×
2.52×
Q3 24
11.13×
Q2 24
0.56×
Q1 24
-1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

IPG
IPG

MDE$619.0M29%
IAC$574.9M27%
Other$527.9M25%
SCE$413.8M19%

Related Comparisons